# Health minister Aaron Motsoaledi has welcomed the South African Health Products Regulatory Authority’s decision to approve Lenacapavir. South Africa is the first country on the continent to approve the groundbreaking twice-a-year anti-HIV injection. Lenacapavir is a revolutionary long-acting drug that offers six months of protection. Motsoaledi says the drug has the potential to address critical gaps in current HIV prevention methods:
Minister Motsoaledi says the groundbreaking anti-HIV injection Lenacapavir is a game-changer [SOUND]
ENG MotsoalediOnLenacapavir